High Tide Inc. operates as a vertically-integrated company in the cannabis market in Canada, the United States, and internationally.
High Tide Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CA$8.05|
|52 Week High||CA$2.25|
|52 Week Low||CA$16.95|
|1 Month Change||-12.50%|
|3 Month Change||-18.85%|
|1 Year Change||235.42%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||34.17%|
Recent News & Updates
Is High Tide (CVE:HITI) Weighed On By Its Debt Load?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
|HITI||CA Pharmaceuticals||CA Market|
Return vs Industry: HITI exceeded the Canadian Pharmaceuticals industry which returned 27% over the past year.
Return vs Market: HITI exceeded the Canadian Market which returned 28.6% over the past year.
Stable Share Price: HITI is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: HITI's weekly volatility has decreased from 14% to 8% over the past year.
About the Company
High Tide Inc. operates as a vertically-integrated company in the cannabis market in Canada, the United States, and internationally. It engages in the design, manufacture, and distribution of smoking accessories and cannabis lifestyle products. It is also involved in the wholesale and retailing of cannabis products, as well as operates and franchises licensed retail cannabis stores.
High Tide Fundamentals Summary
|HITI fundamental statistics|
Is HITI overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|HITI income statement (TTM)|
|Cost of Revenue||CA$96.96m|
Last Reported Earnings
Jul 31, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.97|
|Net Profit Margin||-21.16%|
How did HITI perform over the long term?See historical performance and comparison
Is High Tide undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: HITI (CA$8.05) is trading below our estimate of fair value (CA$27.41)
Significantly Below Fair Value: HITI is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: HITI is unprofitable, so we can't compare its PE Ratio to the Canadian Pharmaceuticals industry average.
PE vs Market: HITI is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate HITI's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: HITI is overvalued based on its PB Ratio (3x) compared to the CA Pharmaceuticals industry average (2.6x).
How is High Tide forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HITI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: HITI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: HITI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: HITI's revenue (38% per year) is forecast to grow faster than the Canadian market (6.1% per year).
High Growth Revenue: HITI's revenue (38% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HITI's Return on Equity is forecast to be high in 3 years time
How has High Tide performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: HITI is currently unprofitable.
Growing Profit Margin: HITI is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: HITI is unprofitable, and losses have increased over the past 5 years at a rate of 45.2% per year.
Accelerating Growth: Unable to compare HITI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HITI is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (115.1%).
Return on Equity
High ROE: HITI has a negative Return on Equity (-21.92%), as it is currently unprofitable.
How is High Tide's financial position?
Financial Position Analysis
Short Term Liabilities: HITI's short term assets (CA$55.2M) exceed its short term liabilities (CA$34.1M).
Long Term Liabilities: HITI's short term assets (CA$55.2M) exceed its long term liabilities (CA$53.3M).
Debt to Equity History and Analysis
Debt Level: HITI's debt to equity ratio (17.7%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if HITI's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HITI has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if HITI has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is High Tide current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate HITI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate HITI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if HITI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HITI's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of HITI's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Raj Grover (39 yo)
Mr. Harkirat Grover also known as Raj, is Founder, Chief Executive Officer, President of High Tide Inc. since February 2018 and serves as its Director since February 08, 2018 and serves as Executive Chairm...
CEO Compensation Analysis
Compensation vs Market: Raj's total compensation ($USD408.95K) is below average for companies of similar size in the Canadian market ($USD849.90K).
Compensation vs Earnings: Raj's compensation has been consistent with company performance over the past year.
Experienced Management: HITI's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Experienced Board: HITI's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 231.8%.
High Tide Inc.'s employee growth, exchange listings and data sources
- Name: High Tide Inc.
- Ticker: HITI
- Exchange: TSXV
- Founded: 2009
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: CA$424.264m
- Shares outstanding: 52.70m
- Website: https://www.hightideinc.com
- High Tide Inc.
- 11127 - 15 Street NE
- Suite 112
- T3K 2M4
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/22 22:45|
|End of Day Share Price||2021/09/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.